Eli Lilly and Company

Eli Lilly and Company

Eli Lilly and Company is an american global pharmaceutical company founded by Eli Lilly.

Lilly was founded in 1876 by Colonel Eli Lilly. His ambition was creating quality medicines that met real needs, during a time of deceptive medicine being sold by con men.

Disease Areas

Eli lilly and Co. mainly focus on several types of diseases for their medicines.

  • Diabetes
  • Cancer
  • Immunology
  • Pain
  • Neurodegradation
COVID-19 Response

On February 3rd, 2020, the company began to involves themselves in the pandemic by donating funds to the Red Cross and Direct Relief. On March 12th, it was announced that they would partner with AbCellera to develop antibody products in hopes to treat and prevent Covid-19.

A drive thru testing site was designated by the company, solely for health care workers, public safety, fire, ambulance, and public servants.

Timeline

November 19, 2020
Eli Lilly and Company and Ypsomed announces a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly's connected diabetes solutions.
November 5, 2020
Eli Lilly and Company announces that Aarti Shah, Ph.D., senior vice president and chief information and digital officer, will retire in the first half of 2021.
June 8, 2020
Eli Lilly and Company announces its partner Junshi Biosciences (HKEX: 1877) has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19.

People

Name
Role
LinkedIn

Abhinay Joshi

Employee

Abhisek Mazumdar

Employee

Abhishek Tiwari

Employee

Ahsas Ranjan

Employee

AJ Vandermeyden

Employee

Akshay Jain

Employee

Alan Codkind

Employee

Alan Gould

Employee

Alan Houser

Employee

Aldona Greenwood

Employee

Alec Webster

Employee

Aleksander Lim Kristensen

Employee

Alex Simpson

Employee

Alex Therrien

Employee

Alexander Pavlov

Employee

Alexandra Buttke

Employee

Ali Dorward

Employee

Alireza Mehdizadeh Kashani

Employee

Alison Furtos

Employee

Álvaro Guirao López

Employee

Aman Chawla

Employee

Amber Illig

Employee

Amber Martin

Employee

Amy Jorgenson

Employee

Andre Eleuterio

Employee

Page 1 of 16
...

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Eli Lilly and Company
January 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2020 financial results on Friday, January 29, 2021. Lilly will...
Eli Lilly and Company
January 15, 2021
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a $30 million limited partner investment in Unseen Capital Health Fund LP, a newly-formed...
Innovent Biologics
January 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
Eli Lilly and Company
January 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Donanemab, an investigational antibody that targets a modified form of beta amyloid called N3pG, showed significant slowing of decline in a...
Johnson Fistel, LLP
December 22, 2020
www.prnewswire.com:443
/PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Prevail Therapeutics Inc....
Eli Lilly and Company
December 18, 2020
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to begin a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with...
Meagan Simpson
December 16, 2020
BetaKit
Vancouver biotech company AbCellera Biologics has officially announced the close of its IPO on the Nasdaq, pulling in gross proceeds of $555.5 million.
Eli Lilly and Company
December 15, 2020
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Prevail Therapeutics Inc. (NASDAQ: PRVL) today announced a definitive agreement for Lilly to acquire...
Eli Lilly and Company
December 14, 2020
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that qualified physicians may now enroll patients in the study New IDEAS: Imaging...
Eli Lilly and Company
December 11, 2020
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published...
Pharmaceutical Research and Manufacturers of America (PhRMA)
December 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) is pleased to announce that David Ricks, chairman and CEO of Eli Lilly and...
Eli Lilly and Company
December 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline...
Eli Lilly and Company
December 8, 2020
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2021 on Tuesday, December 15, 2020. Lilly will also conduct a...
BioSpace
December 4, 2020
BioSpace
Eli Lilly and Company (NYSE: LLY) and UnitedHealth Group (NYSE: UNH) today announced a partnership to conduct a pragmatic study of bamlanivimab (LY-CoV555) in high-risk, COVID-19 infected individuals.
Eli Lilly and Company
December 4, 2020
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and UnitedHealth Group (NYSE: UNH) today announced a partnership to conduct a pragmatic study of bamlanivimab...
Eli Lilly and Company
December 2, 2020
www.prnewswire.com:443
/PRNewswire/ -- The U.S. government has purchased 650,000 additional doses of Eli Lilly and Company's (NYSE: LLY) neutralizing antibody bamlanivimab...
Legacy Health Endowment
December 2, 2020
www.prnewswire.com:443
/PRNewswire/ -- Thousands of people in Stanislaus and Merced counties can now access free or low-cost insulin through a groundbreaking partnership. Building...
December 2, 2020
BioSpace
Gyroscope Therapeutics Announces Appointments of Industry Veterans in Gene Therapy, Ophthalmology and Biopharmaceuticals to Its Board of Directors - read this article along with other careers information, tips and advice on BioSpace
Eli Lilly and Company
November 24, 2020
www.prnewswire.com:443
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020. Michael...
Eli Lilly and Company
November 20, 2020
www.prnewswire.com:443
/PRNewswire/ -- Health Canada today granted authorization under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation...
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.